2026 NPPES data Allergy & Immunology Physician NPI 1396107371
Verify on CMS →

MARK MCCABE

Allergy & Immunology Physician in TYLER, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
423
Medicare Part D claims · 133 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$262.88
14 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK MCCABE is a Allergy & Immunology Physician ([object Object]) practicing in TYLER, Texas with a Medicare Part D prescribing footprint of 423 claims across 133 beneficiaries — 36% brand-name prescribing . Industry payments of $262.88 across 14 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK MCCABE filed 423 Medicare Part D claims in 2023 across TYLER, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK MCCABE practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK MCCABE at a glance

Quality data not reported

NPI registry status

Active

Issued 03/28/2016

NPI 1396107371

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

423 45% vs specialty avg

2023 prescription claims

Specialty avg: 764

Specialty distribution in Texas

How Allergy & Immunology Physician compares to other specialties among Texas providers

Texas providers

Allergy & Immunology Physician share within Texas

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK MCCABE is a Allergy & Immunology Physician provider practicing in TYLER, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1396107371. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK MCCABE appears in the CMS NPPES registry as a Allergy & Immunology Physician provider at 1128 MEDICAL DR, TYLER, TX, 75701, with a listed phone of (903) 593-8273. NPI 1396107371 was issued on 03/28/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCCABE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 423 prescription claims written by this provider, covering 133 Medicare beneficiaries and totaling roughly $75K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1128 MEDICAL DR
TYLER, TX 75701

Provider Details

NPI 1396107371
Specialty Allergy & Immunology Physician
Gender Male
NPI Issued 03/28/2016

Hospital and facility affiliations

Facilities where MARK MCCABE bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ALLERGY PARTNERS OF TEXAS INC
TYLER, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK MCCABE. Source: openpaymentsdata.cms.gov.

Total received

$263

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MARK MCCABE. To verify MARK MCCABE's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARK MCCABE — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 423 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

423
Total Claims
$75K
Total Drug Cost
133
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
605
Total Day Supply
17,081
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$65K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
1.01
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Azelastine Hcl
134
Symbicort
Budesonide/Formoterol Fumarate
53
Fluticasone Propionate
46
Epinephrine
21
Ipratropium Bromide
21
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
21
Montelukast Sodium
17
Famotidine
12
Spiriva Respimat
Tiotropium Bromide
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How MARK MCCABE fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

MARK MCCABE's 423 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as MCCABE.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK MCCABE's specialty?
MARK MCCABE specializes in Allergy & Immunology Physician and practices in TYLER, Texas.
How much does MARK MCCABE prescribe under Medicare Part D?
In 2023, MARK MCCABE wrote 423 Medicare Part D claims totaling $75K in drug costs for 133 beneficiaries.
Where is MARK MCCABE located?
MARK MCCABE is located at 1128 MEDICAL DR, TYLER, TX, 75701. Phone: (903) 593-8273.
What is MARK MCCABE's NPI number?
MARK MCCABE's National Provider Identifier (NPI) is 1396107371, issued on 03/28/2016.
Does MARK MCCABE prescribe more brand-name or generic drugs?
MARK MCCABE's prescribing is 36% brand-name and 64% generic drugs by claim count, with $65K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does MARK MCCABE prescribe most often?
Based on 2023 Medicare Part D data, MARK MCCABE's most frequently prescribed drugs include Azelastine Hcl, Symbicort, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK MCCABE accept Medicare?
MARK MCCABE appears in CMS Medicare data with 423 Part D claims and 133 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK MCCABE's credentials?
MARK MCCABE's NPI is 1396107371. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology